NCT06513806View on ClinicalTrials.gov

Granisetron Versus Pethidine in Treatment of Post Spinal Shivering in Cesarean Sections

PHASE4CompletedINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

September 25, 2024

Study Completion Date

September 28, 2024

Conditions
Anesthesia; Adverse Effect, Spinal and Epidural
Interventions
DRUG

Granisetron 1 Mg/mL Intravenous Solution

will receive granisetron 3 mg iv bolus

DRUG

Pethidin

will receive pethidine 25 mg iv bolus

Trial Locations (1)

Unknown

Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT06513806 - Granisetron Versus Pethidine in Treatment of Post Spinal Shivering in Cesarean Sections | Biotech Hunter | Biotech Hunter